KMT2A and central nervous system cancer: GSEA revealed significant negative enrichment for the MLL1_MLL2 core genes set in disulfiram-treated SF188 and GPC16 cells, demonstrating that genes regulated by MLL1 and MLL2 are affected by disulfiram treatment in both glioma cell line and primary cells (Fig. 6A).